Metabonomic profiling of bladder cancer

Metabonomic profiling of bladder cancer

10.1021/pr500966h

Saved in:

Bibliographic Details
Main Authors:	Chan E.C.Y, Pasikanti K.K, Hong Y, Ho P.C, Mahendran R, Raman Nee Mani L, Chiong E., Esuvaranathan K.
Other Authors:	PHARMACY
Format:	Review
Published:	American Chemical Society 2016
Online Access:	http://scholarbank.nus.edu.sg/handle/10635/127798
Tags:	Add Tag No Tags, Be the first to tag this record!
Institution:	National University of Singapore

Similar Items

Noninvasive urinary metabonomic diagnosis of human bladder cancer
by: Pasikanti, K.K., et al.
Published: (2014)

METABONOMIC PROFILING OF BLADDER CANCER
by: PASIKANTI KISHORE KUMAR
Published: (2011)

Urinary metabotyping of bladder cancer using two-dimensional gas chromatography time-of-flight mass spectrometry
by: Pasikanti, K.K., et al.
Published: (2014)

Trend analysis of metabonomics and systematic review of metabonomics-derived cancer marker metabolites
by: Ng, D.J.Y., et al.
Published: (2014)

Development and validation of a gas chromatography/mass spectrometry metabonomic platform for the global profiling of urinary metabolites
by: Pasikanti, K.K., et al.
Published: (2014)

Metabonomics
by: Yong Chan, E.C., et al.
Published: (2014)

Metabonomic profiling of TASTPM transgenic Alzheimer's disease mouse model
by: Hu, Z.-P., et al.
Published: (2014)

Comparative evaluation of software for retention time alignment of gas chromatography/time-of-flight mass spectrometry-based metabonomic data
by: Koh, Y., et al.
Published: (2014)

Non-invasive fecal metabonomic detection of colorectal cancer
by: Phua, L.C., et al.
Published: (2014)

New therapies for non-muscle-invasive bladder cancer
by: Chiong, E., et al.
Published: (2011)

An automated Pearson's correlation change classification (APC3) approach for GC/MS metabonomic data using total ion chromatograms (TICs)
by: Prakash, B.D., et al.
Published: (2014)

Gas chromatography/mass spectrometry in metabolic profiling of biological fluids
by: Pasikanti, K.K., et al.
Published: (2014)

Global gas chromatography/time-of-flight mass spectrometry (GC/TOFMS)-based metabonomic profiling of lyophilized human feces
by: Phua, L.C., et al.
Published: (2014)

Nonviral cytokine gene therapy on an orthotopic bladder cancer model
by: Wu, Q., et al.
Published: (2011)

Metabonomics investigation of human urine after ingestion of green tea with gas chromatography/mass spectrometry, liquid chromatography/mass spectrometry and 1H NMR spectroscopy
by: Law, W.S., et al.
Published: (2014)

Metabonomics investigation of human urine after ingestion of green tea with gas chromatography/mass spectrometry, liquid chromatography/mass spectrometry and1H NMR spectroscopy
by: Law, W.S., et al.
Published: (2011)

Metabolic footprinting of tumorigenic and nontumorigenic uroepithelial cells using two-dimensional gas chromatography time-of-flight mass spectrometry
by: Pasikanti, K.K., et al.
Published: (2014)

Predictive value of p53 and pRb expression in superficial bladder cancer patients treated with BCG and interferon-alpha
by: Esuvaranathan, K., et al.
Published: (2012)

Predictive value of p53 and pRb expression in superficial bladder cancer patients treated with BCG and interferon-alpha
by: Esuvaranathan, K., et al.
Published: (2011)

Best of AUA 2013: Bladder cancer
by: Chiong, E.
Published: (2016)

The signalling pathway for BCG-induced interleukin-6 production in human bladder cancer cells
by: Zhang, Y., et al.
Published: (2011)

NRAMP1 and hGPX1 gene polymorphism and response to bacillus Calmette-Guérin therapy for bladder cancer
by: Chiong, E., et al.
Published: (2014)

Global urinary metabolic profiling procedures using gas chromatography-mass spectrometry
by: Chan, E.C.Y., et al.
Published: (2014)

Beyond diabetes: The role of metformin in non-muscle invasive bladder cancer
by: Wang, Ziting, et al.
Published: (2021)

Internalization of Mycobacterium bovis, Bacillus Calmette Guerin, by bladder cancer cells is cytotoxic
by: Pook, S.-H., et al.
Published: (2014)

Internalization of Mycobacterium bovis, Bacillus Calmette Guerin, by bladder cancer cells is cytotoxic.
by: Pook, S.H., et al.
Published: (2011)

Mucoadhesive polyacrylamide nanogel as a potential hydrophobic drug carrier for intravesical bladder cancer therapy
by: Lu S., et al.
Published: (2016)

Evaluation of lymphocytic responses after treatment with bacillus Calmette-Guerin and interferon-α 2b for superficial bladder cancer
by: Gan, Y.-H., et al.
Published: (2011)

Tumor and microenvironment modification during progression of murine orthotopic bladder cancer
by: Tham, S.M., et al.
Published: (2014)

N-acetylcysteine augments the cellular redox changes and cytotoxic activity of internalized mycobacterium bovis in human bladder cancer cells
by: Pook, S.H., et al.
Published: (2011)

Effects of bacillus Calmette-Guerin and interferon-α-2b on human bladder cancer in vitro
by: Zhang, Y., et al.
Published: (2011)

Local Immune Stimulation by Intravesical Instillation of Baculovirus to Enable Bladder Cancer Therapy
by: Ang, W.X, et al.
Published: (2020)

Antitumour immunity of Bacillus Calmette-Guerin and interferon alpha in murine bladder cancer
by: Gan, Y.H., et al.
Published: (2011)

Wirelessly Activated Nanotherapeutics for In Vivo Programmable Photodynamic-Chemotherapy of Orthotopic Bladder Cancer
by: Sun, Bowen, et al.
Published: (2022)

A murine orthotopic bladder tumor model and tumor detection system
by: Tham S.M., et al.
Published: (2018)

Effects of bacillus Calmette-Guerin and interferon α-2b on cytokine production in human bladder cancer cell lines
by: Zhang, Y.E., et al.
Published: (2011)

Detection of clinical mesenchymal cancer cells from bladder wash urine for real-time detection and prognosis
by: Khoo, B.L., et al.
Published: (2021)

Bacillus Calmette-Guerin induces rapid gene expression changes in human bladder cancer cell lines that may modulate its survival
by: Rahmat, Juwita N, et al.
Published: (2021)

METABONOMICS IN THE STUDY OF EYE DISEASES
by: CHEN LIYAN
Published: (2015)

Intravesical High Dose BCG Tokyo and Low Dose BCG Tokyowith GMCSF + IFNa Induce Systemic Immunity in a MurineOrthotopic Bladder Cancer Model
by: Tham, Sin Mun, et al.
Published: (2021)